Stephen L. Sabba, Director at LIGAND PHARMACEUTICALS INC (LGND), sold 2,145 shares at $254.00 ($545K) on 2026-06-16, disclosed to the SEC on 2026-06-18.
Seasonal sale ($545k) by Director — this insider has traded LGND in June in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| LGND | SELL | 2024-03-07 | $281K | — | Filing → |
| LGND | SELL | 2023-05-12 | $988K | — | Filing → |
| LGND | SELL | 2021-02-11 | $6.0M | — | Filing → |